Identification and Development of Therapeutics for COVID-19
2021; American Society for Microbiology; Volume: 6; Issue: 6 Linguagem: Inglês
10.1128/msystems.00233-21
ISSN2379-5077
AutoresHalie M. Rando, Nils Wellhausen, Soumita Ghosh, Alexandra Lee, Anna Ada Dattoli, Fengling Hu, James Brian Byrd, Diane N. Rafizadeh, Ronan Lordan, Yanjun Qi, Yuchen Sun, Christian Brueffer, Jeffrey Field, Marouen Ben Guebila, Nafisa M. Jadavji, Ashwin N. Skelly, Bharath Ramsundar, Jinhui Wang, Rishi R. Goel, YoSon Park, Simina M. Boca, Anthony Gitter, Casey S. Greene,
Tópico(s)Long-Term Effects of COVID-19
ResumoAfter emerging in China in late 2019, the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread worldwide, and as of mid-2021, it remains a significant threat globally. Only a few coronaviruses are known to infect humans, and only two cause infections similar in severity to SARS-CoV-2:
Referência(s)